Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 105

Similar articles for PubMed (Select 24307163)

1.

Antiplatelet therapy to prevent recurrent stroke: Three good options.

Mansoor AH, Mujtaba MT, Silver B.

Cleve Clin J Med. 2013 Dec;80(12):787-95. doi: 10.3949/ccjm.80a.12149. Review.

2.

Front-loading with clopidogrel plus aspirin followed by dual antiplatelet therapy in the prevention of early stroke recurrence.

Censori B.

Expert Rev Neurother. 2014 Jul;14(7):723-34. doi: 10.1586/14737175.2014.923758. Epub 2014 May 31. Review.

PMID:
24881887
3.

Dual antiplatelet therapy (clopidogrel and aspirin) is associated with increased all-cause mortality after carotid revascularization for asymptomatic carotid disease.

Alcocer F, Novak Z, Combs BR, Lowman B, Passman MA, Mujib M, Jordan WD.

J Vasc Surg. 2014 Apr;59(4):950-5. doi: 10.1016/j.jvs.2013.10.087. Epub 2014 Jan 31.

PMID:
24491238
4.

Switching from aspirin to clopidogrel in patients with aspirin resistance after an ischemic stroke. Is it a good solution?

Castilla-Guerra L, Fernandez-Moreno Mdel C, Navas-Alcantara MS, Jimenez-Gonzalo F.

Eur J Intern Med. 2014 Mar;25(3):e40-1. doi: 10.1016/j.ejim.2014.01.007. Epub 2014 Jan 29. No abstract available.

PMID:
24484620
5.

Evaluation of antiplatelet agents for secondary prevention of stroke using mixed treatment comparison meta-analysis.

Malloy RJ, Kanaan AO, Silva MA, Donovan JL.

Clin Ther. 2013 Oct;35(10):1490-1500.e7. doi: 10.1016/j.clinthera.2013.09.004.

PMID:
24139421
6.

Risk-benefit profile of long-term dual- versus single-antiplatelet therapy among patients with ischemic stroke: a systematic review and meta-analysis.

Lee M, Saver JL, Hong KS, Rao NM, Wu YL, Ovbiagele B.

Ann Intern Med. 2013 Oct 1;159(7):463-70. doi: 10.7326/0003-4819-159-7-201310010-00006. Review.

PMID:
24081287
7.

Discontinuation of antiplatelet study medication and risk of recurrent stroke and cardiovascular events: results from the PRoFESS study.

Weimar C, Cotton D, Sha N, Sacco RL, Bath PM, Weber R, Diener HC.

Cerebrovasc Dis. 2013;35(6):538-43. doi: 10.1159/000351144. Epub 2013 Jun 25.

PMID:
23816610
8.

[Secondary prevention with clopidogrel after TIA or stroke].

Zuurbier SM, Vermeer SE, Hilkens PH, Algra A, Roos YB.

Ned Tijdschr Geneeskd. 2013;157(25):A5836. Review. Dutch.

PMID:
23777963
9.

Aspirin and clopidogrel for prevention of ischemic stroke.

Thomson RM, Anderson DC.

Curr Neurol Neurosci Rep. 2013 Feb;13(2):327. doi: 10.1007/s11910-012-0327-y. Review.

PMID:
23299823
10.

Acute ischemic cerebrovascular events on antiplatelet therapy: what is the optimal prevention strategy?

Milionis H, Michel P.

Curr Pharm Des. 2013;19(21):3788-94. Review.

PMID:
23286434
11.

Prevalence of ex vivo high on-treatment platelet reactivity on antiplatelet therapy after transient ischemic attack or ischemic stroke on the PFA-100(®) and VerifyNow(®).

Kinsella JA, Tobin WO, Cox D, Coughlan T, Collins R, O'Neill D, Murphy RP, McCabe DJ.

J Stroke Cerebrovasc Dis. 2013 Oct;22(7):e84-92. doi: 10.1016/j.jstrokecerebrovasdis.2012.07.012. Epub 2012 Sep 13.

PMID:
22981273
12.

Antiplatelet therapy in cerebrovascular disorders.

Weber R, Brenck J, Diener HC.

Handb Exp Pharmacol. 2012;(210):519-46. doi: 10.1007/978-3-642-29423-5_21. Review.

PMID:
22918745
13.

Investigating incoherence gives insight: clopidogrel is equivalent to extended-release dipyridamole plus aspirin in secondary stroke prevention.

Dewilde S, Hawkins N.

J Clin Epidemiol. 2012 Aug;65(8):835-45. doi: 10.1016/j.jclinepi.2012.01.019. Review.

PMID:
22726765
14.

Antiplatelets in secondary stroke prevention: should clopidogrel be the first choice?

Aw D, Sharma JC.

Postgrad Med J. 2012 Jan;88(1035):34-7. doi: 10.1136/postgradmedj-2011-130100. Epub 2011 Nov 25. Review.

PMID:
22121248
15.

Clopidogrel and modified-release dipyridamole for the prevention of occlusive vascular events (review of Technology Appraisal No. 90): a systematic review and economic analysis.

Greenhalgh J, Bagust A, Boland A, Martin Saborido C, Oyee J, Blundell M, Dundar Y, Dickson R, Proudlove C, Fisher M.

Health Technol Assess. 2011 Sep;15(31):1-178. doi: 10.3310/hta15310. Review.

16.

New insights in antiplatelet therapy for patients with ischemic stroke.

Chaturvedi S, Bhattacharya P.

Neurologist. 2011 Sep;17(5):255-62. doi: 10.1097/NRL.0b013e318224ed70. Review.

PMID:
21881467
17.

Review and management of side effects associated with antiplatelet therapy for prevention of recurrent cerebrovascular events.

Guthrie R.

Adv Ther. 2011 Jun;28(6):473-82. doi: 10.1007/s12325-011-0026-0. Epub 2011 May 3. Review.

PMID:
21547541
18.

Secondary prevention in the acute and early chronic phase after ischaemic stroke and transient ischaemic attacks with antiplatelet drugs--is antiplatelet monotherapy still reasonable?

Diener HC, Weber R, Weimar C, Röther J.

Int J Clin Pract. 2011 May;65(5):531-5. doi: 10.1111/j.1742-1241.2010.02621.x. Review. No abstract available.

PMID:
21489077
20.

Antiplatelet resistance in stroke.

Topçuoglu MA, Arsava EM, Ay H.

Expert Rev Neurother. 2011 Feb;11(2):251-63. doi: 10.1586/ern.10.203. Review.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk